Chloramphenicol

Medicom Recognized as One of the Most Promising Health IT Imaging Vendors of 2024 by KLAS Research

Retrieved on: 
Friday, February 16, 2024
Chloramphenicol, Emerging, Research report, Research, Imaging, KLAS, Partnership

RALEIGH, N.C., Feb. 16, 2024 /PRNewswire/ -- Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report.

Key Points: 
  • RALEIGH, N.C., Feb. 16, 2024 /PRNewswire/ -- Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report.
  • In a recent report released on January 16th, 2024, KLAS Research showcased Medicom alongside other healthcare IT vendors across various market segments.
  • KLAS Research conducts annual interviews with healthcare organizations to assess their experiences with healthcare IT vendors, aiming to identify the top innovative and relevant contributors.
  • "Medicom's recognition in the Imaging category by KLAS Research underscores our unwavering commitment to innovation and excellence in healthcare interoperability," emphasized Malcolm Benitz, President of Medicom.

Petzey Addresses Unidentified Respiratory Illness Spreading Amongst Dogs

Retrieved on: 
Wednesday, December 13, 2023
Family, Health, Consumer, Infectious Diseases, Pets, Veterinary, Pet, Immune system, Pneumonia, Infection, Azithromycin, Chloramphenicol, Risk, Vaccination, Bordetella, Steroid, Weakness, Dehydration, Cold, Therapy, Human, Wheeze, Parent, Somatic symptom disorder, Dog, Lethargy, Vaccine, Doxycycline

Petzey , the leading on-demand mobile pet telehealth and wellness app, is addressing the recent outbreak of an unidentified respiratory illness affecting dogs across the country, from Oregon to Florida.

Key Points: 
  • Petzey , the leading on-demand mobile pet telehealth and wellness app, is addressing the recent outbreak of an unidentified respiratory illness affecting dogs across the country, from Oregon to Florida.
  • The condition, which has yet to be officially named, presents symptoms similar to known respiratory viruses and subsequent bacterial infections.
  • The illness can progress to pneumonia, posing a severe health risk.
  • Dr. Danny Cox, Chief Veterinary Medical Officer at Petzey, states, “What we understand about this new respiratory bug is its resemblance to other respiratory viruses like last year’s canine flu, canine parainfluenza, and treatable bacterial infections such as bordetella and pneumococcal pneumonia.

Medicom Technologies Inc. and Onsite Women's Health Establish Strategic Partnership Impacting Early Breast Cancer Detection and Treatment

Retrieved on: 
Monday, October 30, 2023
Chloramphenicol, Organization, Health, Patient, Diagnosis, Breast cancer, Partnership, Medical imaging, Onshore

RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Medicom Technologies Inc. (Medicom) proudly announces its partnership with Onsite Women's Health (Onsite), a leading national provider of breast health services.

Key Points: 
  • RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Medicom Technologies Inc. (Medicom) proudly announces its partnership with Onsite Women's Health (Onsite), a leading national provider of breast health services.
  • With a dedicated mission to elevate the patient and clinician journey through advancements in medical image exchange, Medicom and Onsite Women's Health set the stage for transformative advancements in breast cancer detection.
  • In partnership with forward-thinking providers across the country, Onsite offers comprehensive breast imaging services and is committed to saving more women's lives through earlier cancer detection.
  • At Medicom, we recognize the critical role of interoperability in facilitating timely and accurate diagnoses, particularly in breast cancer detection," shares Malcolm Benitz, President of Medicom.

Medicom Technologies Named as a Sample Vendor in Two Gartner® Hype Cycle™ Reports

Retrieved on: 
Monday, September 18, 2023
Real, Main Street, Analytics, Therapy, Gartner, Chloramphenicol, Policy, Research, RWD, Gartner hype cycle, Real world data, Organization, AI, Ecosystem, R, HCLS, D, Pharmaceutical industry

RALEIGH, N.C., Sept. 18, 2023 /PRNewswire/ -- For the second consecutive year, Medicom Technologies, Inc. ( Medicom ) proudly announces its inclusion as a Sample Vendor in two highly anticipated Gartner Hype Cycle reports for Health Care and Life Sciences (HCLS) organizations.

Key Points: 
  • RALEIGH, N.C., Sept. 18, 2023 /PRNewswire/ -- For the second consecutive year, Medicom Technologies, Inc. ( Medicom ) proudly announces its inclusion as a Sample Vendor in two highly anticipated Gartner Hype Cycle reports for Health Care and Life Sciences (HCLS) organizations.
  • The recently published reports in July 2023 showcase Medicom's instrumental role in the evolving landscape of data monetization within the healthcare sector.
  • Medicom is featured in the Gartner Hype Cycle for Healthcare Data, Analytics, and AI, 2023, as well as the Gartner Hype Cycle for Life Science Clinical Development, 2023.
  • Medicom's repeat inclusion as a Sample Vendor in these reports serves as a testament to its pivotal role in facilitating groundbreaking research aimed at improving patient outcomes.

American Dental Association Foundation Kicks Off the 21st Year of Give Kids A Smile® With Exclusive National Sponsors, Henry Schein and Colgate-Palmolive

Retrieved on: 
Friday, February 3, 2023
Family, Philanthropy, Consumer, Other Communications, Parenting, Dental, Foundation, Children, Other Consumer, Communications, Other Philanthropy, Health, Business communications operations management, CL, Give Kids the World Village, National Advisory Committee on Immunization, NYSE, DASH, American Dental Association, Sunstar, Dentist, Chloramphenicol, Premier, Dentistry, Health equity, Centrix, Partnership, Schein, Volunteering, Multimedia, Chair, Ansell, Community, Colgate-Palmolive, Pharmaceutical industry

The American Dental Association Foundation announces the 21st year of its Give Kids A Smile (GKAS) program, which officially launches today at this year’s national kick-off event in St. Louis, MO where the program first began.

Key Points: 
  • The American Dental Association Foundation announces the 21st year of its Give Kids A Smile (GKAS) program, which officially launches today at this year’s national kick-off event in St. Louis, MO where the program first began.
  • “What began as a grassroots effort in St. Louis has become a national movement to ensure access to quality oral health care for all children,” said Dr. Craig Armstrong, Chair, American Dental Association Foundation.
  • “The success of GKAS would not be possible without dental professionals who volunteer at local events each year in addition to national sponsors, Henry Schein, and Colgate.
  • “Henry Schein is pleased to be an exclusive national partner of the ADAF’s signature access-to-care program Give Kids A Smile since its national launch in 2003,” said Dave Steck, Vice President and General Manager, U.S.

David Donnelly joins PADM Medical Canada as President and General Manager

Retrieved on: 
Tuesday, February 7, 2023
MB, H.L. Stevens & Company, McMaster University, CHS, HSCN, DeGroote School of Business, Business, MEDLINE, Commerce, Chloramphenicol, Michael G. DeGroote School of Medicine, Business development, Interior design, Nursing, Marketing

WINNIPEG, MB, Feb. 7, 2023 /PRNewswire/ - PADM Medical Canada is pleased to announce the appointment of David Donnelly, a seasoned healthcare industry executive with over 30 years of success and experience in the healthcare and medical device industry, to the position of President and General Manager

Key Points: 
  • WINNIPEG, MB, Feb. 7, 2023 /PRNewswire/ - PADM Medical Canada is pleased to announce the appointment of David Donnelly, a seasoned healthcare industry executive with over 30 years of success and experience in the healthcare and medical device industry, to the position of President and General Manager
    PADM Medical Canada is pleased to announce that David Donnelly has joined the organization as our new President and General Manager effective February 1, 2023.
  • David brings over 30 years of success and experience in the healthcare and medical device industry.
  • David has extensive senior management experience in healthcare manufacturing and distribution in the functional areas of Marketing, Business Development and Sales.
  • Prior to joining PADM Medical Canada, David held leadership positions with CHS, Medicom, The Stevens Company and Medline.

Contextual Intelligence Leader Announces Free, Industry-Wide Contextual Certification Program

Retrieved on: 
Tuesday, January 24, 2023
Contextual, OMD, Research, Saudi Research and Marketing Group, Certification, Advertising, Metadata, Immediate Media Company, PII, History, Market, Accreditation, CTV, DACH, Intelligence, Chloramphenicol, Media Rating Council, Management

The certification is intended to educate media planners and buyers on contextual advertising and GumGum offerings, as the leader in contextual intelligence.

Key Points: 
  • The certification is intended to educate media planners and buyers on contextual advertising and GumGum offerings, as the leader in contextual intelligence.
  • The announcement follows the company’s pilot certification program launched in the Germany, Austria and Switzerland (DACH) regions last year.
  • GumGum’s contextual certification program is a free, flexible, self-paced training and assessment that will empower individuals to navigate the complex contextual advertising landscape.
  • The program is 30 minutes-long and covers the history of contextual advertising, contextual strategy, a look behind the lens on the technology that makes contextual intelligence possible and information on the Media Rating Council who manage measurement accreditation for the advertising industry.

Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)

Retrieved on: 
Tuesday, December 20, 2022
Severe cognitive impairment, OSD, Partnership, OTCQB, PGA, BAK, Health Canada, Glaucoma, AQS, CCO, News, Patient, Benzalkonium chloride, IOP, Ocular hypertension, PF, Chloramphenicol, Pharmaceutical industry

Affecting more than 700,000 people in Canada, glaucoma is one of the leading causes of blindness in North America.

Key Points: 
  • Affecting more than 700,000 people in Canada, glaucoma is one of the leading causes of blindness in North America.
  • Zimed® PF is the first prostaglandin analog (PGA) that is preservative free and offered in an easy-to-use multi-dose bottle in Canada.
  • “We have heard from the eyecare professionals that there is a need for preservative-free alternatives,” says Grant Larsen, CCO of Aequus Pharma.
  • We look forward to launching Zimed® PF in 2023 and providing Canadians with more treatment options.”

Medicom Helps Source Anonymized Clinical Information for OSIC Data Repository to Further Advance Research and Treatment for Interstitial Lung Diseases

Retrieved on: 
Monday, November 28, 2022
Vicki Belo, Diagnosis, Degenerative disease, Organization, AI, Machine learning, Partnership, Health, Open source, Patient, Database, Biomarker, Association of British HealthTech Industries, RWD, Swiss Personalized Health Network, Motivation, Prognosis, Politics, Research, Ecosystem, HRCT, PHI, IPF, Chloramphenicol, ILD, Idiopathic pulmonary fibrosis, Algorithm, Medical imaging, Pharmaceutical industry

Medicom is helping OSIC continue to add anonymized, comprehensive data sets to its repository.

Key Points: 
  • Medicom is helping OSIC continue to add anonymized, comprehensive data sets to its repository.
  • Based upon the building blocks of Medicom ImageX , Medicom deepMed helps source anonymized clinical information for OSIC and many other life science organizations.
  • Medicom is helping OSIC continue to add anonymized, comprehensive data sets to its repository.
  • Medicom enables providers, patients, and research organizations to search and share data across disparate ecosystems through a decentralized health information network.

PHC Group Releases Newly Revised Mid-Term Plan, the “Value Creation Plan,” Outlining Changes for FY2025 to Accelerate Growth by Advancing Value-Based Healthcare

Retrieved on: 
Wednesday, November 16, 2022
Technology, Medical Devices, Diabetes, Clinical Trials, Software, Hardware, Pharmaceutical, Health, Oncology, Artificial Intelligence, Investment, Hospital, Workflow, Diagnosis, Chloramphenicol, AI, Creation, Health, Digital, IOT, Multimedia, POCT, Health care, Cancer, PHC, Accuro Healthcare Solutions, Internet, Tokyo Stock Exchange, EMR, Point-of-care testing, CGM, Fortis Healthcare, Genetic testing, Patient, Medical imaging, Medical device

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: Shoji Miyazaki, hereafter PHC Group) announces the release of its newly revised Mid-term Plan, the Value Creation Plan*1 for FY2022 to FY2025.

Key Points: 
  • PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: Shoji Miyazaki, hereafter PHC Group) announces the release of its newly revised Mid-term Plan, the Value Creation Plan*1 for FY2022 to FY2025.
  • The primary update in this plan is the introduction of new business growth areas that will enable PHC Group to advance value-based healthcare globally.
  • To contribute to reducing healthcare costs and enhancing treatments, PHC Group will work to integrate and analyze health data.
  • Through this Value Creation Plan, PHC Group is targeting 420 bn/JPY in revenue and 56 bn/JPY in operating profit: